Cargando…
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
The commercial success of bispecific antibodies generally has been hindered by the complexities associated with generating appropriate molecules for both research scale and large scale manufacturing purposes. Bispecific IgG (BsIgG) based on two antibodies that use an identical common light chain can...
Autores principales: | Van Blarcom, Thomas, Lindquist, Kevin, Melton, Zea, Cheung, Wai Ling, Wagstrom, Chris, McDonough, Dan, Valle Oseguera, Cendy, Ding, Sheng, Rossi, Andrea, Potluri, Shobha, Sundar, Purnima, Pitts, Steven, Sirota, Marina, Galindo Casas, Meri, Yan, Yu, Jones, Jeffrey, Roe-Zurz, Zygy, Srivatsa Srinivasan, Surabhi, Zhai, Wenwu, Pons, Jaume, Rajpal, Arvind, Chaparro-Riggers, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825193/ https://www.ncbi.nlm.nih.gov/pubmed/29227213 http://dx.doi.org/10.1080/19420862.2017.1406570 |
Ejemplares similares
-
Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
por: Chen, Shih-Hsun, et al.
Publicado: (2021) -
Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire
por: Yeung, Yik Andy, et al.
Publicado: (2016) -
Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer
por: Zhu, Guoyun, et al.
Publicado: (2019) -
Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer
por: Zhu, Guoyun, et al.
Publicado: (2019) -
Direct control of CAR T cells through small molecule-regulated antibodies
por: Park, Spencer, et al.
Publicado: (2021)